{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T16:53:39Z","timestamp":1775926419469,"version":"3.50.1"},"reference-count":46,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100019016","name":"Assessment of SpondyloArthritis international Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019016","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1136\/annrheumdis-2022-222747","type":"journal-article","created":{"date-parts":[[2022,6,9]],"date-time":"2022-06-09T17:27:08Z","timestamp":1654795628000},"page":"763-772","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":67,"title":["Instrument selection for the ASAS core outcome set for axial spondyloarthritis"],"prefix":"10.1016","volume":"82","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4527-852X","authenticated-orcid":false,"given":"Victoria","family":"Navarro-Comp\u00e1n","sequence":"first","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2016-1744","authenticated-orcid":false,"given":"Anne","family":"Boel","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0682-9533","authenticated-orcid":false,"given":"Annelies","family":"Boonen","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6620-0457","authenticated-orcid":false,"given":"Philip J","family":"Mease","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3009-6229","authenticated-orcid":false,"given":"Maxime","family":"Dougados","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5668-4497","authenticated-orcid":false,"given":"Uta","family":"Kiltz","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0577-6620","authenticated-orcid":false,"given":"Robert B M","family":"Landew\u00e9","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9475-9362","authenticated-orcid":false,"given":"Xenofon","family":"Baraliakos","sequence":"additional","affiliation":[]},{"given":"Wilson","family":"Bautista-Molano","sequence":"additional","affiliation":[]},{"given":"Praveena","family":"Chiowchanwisawakit","sequence":"additional","affiliation":[]},{"given":"Hanne","family":"Dagfinrud","sequence":"additional","affiliation":[]},{"given":"Lara","family":"Fallon","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9727-1189","authenticated-orcid":false,"given":"Marco","family":"Garrido-Cumbrera","sequence":"additional","affiliation":[]},{"given":"Lianne","family":"Gensler","sequence":"additional","affiliation":[]},{"given":"Bassel Kamal","family":"ElZorkany","sequence":"additional","affiliation":[]},{"given":"Nigil","family":"Haroon","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7802-9696","authenticated-orcid":false,"given":"Yu Heng","family":"Kwan","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8411-7972","authenticated-orcid":false,"given":"Pedro M","family":"Machado","sequence":"additional","affiliation":[]},{"given":"Walter","family":"Maksymowych","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2246-1986","authenticated-orcid":false,"given":"Anna","family":"Molto","sequence":"additional","affiliation":[]},{"given":"Natasha","family":"de Peyrecave","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4537-6015","authenticated-orcid":false,"given":"Denis","family":"Poddubnyy","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4840-5069","authenticated-orcid":false,"given":"Mikhail","family":"Protopopov","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8899-9087","authenticated-orcid":false,"given":"Sofia","family":"Ramiro","sequence":"additional","affiliation":[]},{"given":"In-Ho","family":"Song","sequence":"additional","affiliation":[]},{"given":"Salima","family":"van Weely","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5781-158X","authenticated-orcid":false,"given":"D\u00e9sir\u00e9e","family":"van der Heijde","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1136\/annrheumdis-2022-222747_bib1","first-page":"2225","article-title":"Preliminary core sets for endpoints in ankylosing spondylitis. assessments in ankylosing spondylitis Working group","volume":"24","author":"van der Heijde","year":"1997","journal-title":"J Rheumatol"},{"key":"10.1136\/annrheumdis-2022-222747_bib2","first-page":"945","article-title":"Which domains should be included in a core set for endpoints in ankylosing spondylitis? introduction to the ankylosing spondylitis module of OMERACT IV","volume":"26","author":"van der Heijde","year":"1999","journal-title":"J Rheumatol"},{"key":"10.1136\/annrheumdis-2022-222747_bib3","first-page":"1003","article-title":"Ankylosing spondylitis: Plenary discussion and results of voting on selection of domains and some specific instruments","volume":"26","author":"van der Heijde","year":"1999","journal-title":"J Rheumatol"},{"key":"10.1136\/annrheumdis-2022-222747_bib4","first-page":"951","article-title":"Selection of instruments in the core set for DC-ART, SMARD, physical therapy, and clinical record keeping in ankylosing spondylitis. progress report of the ASAS Working Group. assessments in ankylosing spondylitis","volume":"26","author":"van der Heijde","year":"1999","journal-title":"J Rheumatol"},{"key":"10.1136\/annrheumdis-2022-222747_bib5","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/j.semarthrit.2021.07.021","article-title":"The ASAS-OMERACT core domain set for axial spondyloarthritis","volume":"51","author":"Navarro-Comp\u00e1n","year":"2021","journal-title":"Semin Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2022-222747_bib6","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1186\/s13063-017-1978-4","article-title":"The comet Handbook: version 1.0","volume":"18","author":"Williamson","year":"2017","journal-title":"Trials"},{"key":"10.1136\/annrheumdis-2022-222747_bib7","doi-asserted-by":"crossref","first-page":"978","DOI":"10.3899\/jrheum.131307","article-title":"Toward a generalized framework of core measurement areas in clinical trials: a position paper for OMERACT 11","volume":"41","author":"Boers","year":"2014","journal-title":"J Rheumatol"},{"key":"10.1136\/annrheumdis-2022-222747_bib8","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.jclinepi.2013.11.013","article-title":"Developing core outcome measurement sets for clinical trials: OMERACT filter 2.0","volume":"67","author":"Boers","year":"2014","journal-title":"J Clin Epidemiol"},{"key":"10.1136\/annrheumdis-2022-222747_bib9","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1007\/s10067-014-2728-6","article-title":"How well are the ASAS\/OMERACT core outcome sets for ankylosing spondylitis implemented in randomized clinical trials? A systematic literature review","volume":"33","author":"Bautista-Molano","year":"2014","journal-title":"Clin Rheumatol"},{"key":"10.1136\/annrheumdis-2022-222747_bib10","author":"Boers","year":"2018","journal-title":"OMERACT Handbook"},{"key":"10.1136\/annrheumdis-2022-222747_bib11","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1093\/rheumatology\/ket164","article-title":"Percentage of patients with spondyloarthritis in patients referred because of chronic back pain and performance of classification criteria: experience from the spondyloarthritis caught early (space) cohort","volume":"52","author":"van den Berg","year":"2013","journal-title":"Rheumatology"},{"key":"10.1136\/annrheumdis-2022-222747_bib12","doi-asserted-by":"crossref","first-page":"e001450","DOI":"10.1136\/rmdopen-2020-001450","article-title":"Prevalence and distribution of peripheral musculoskeletal manifestations in spondyloarthritis including psoriatic arthritis: results of the worldwide, cross-sectional ASAS-PerSpA study","volume":"7","author":"L\u00f3pez-Medina","year":"2021","journal-title":"RMD Open"},{"key":"10.1136\/annrheumdis-2022-222747_bib13","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1136\/annrheumdis-2012-203201","article-title":"Efficacy and safety of infliximab plus naproxen versus naproxen alone in patients with early, active axial spondyloarthritis: results from the double-blind, placebo-controlled INFAST study, part 1","volume":"73","author":"Sieper","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2022-222747_bib14","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1136\/annrheumdis-2013-204231","article-title":"Efficacy of certolizumab pegol on signs and symptoms of axial spondyloarthritis including ankylosing spondylitis: 24-week results of a double-blind randomised placebo-controlled phase 3 study","volume":"73","author":"Landew\u00e9","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2022-222747_bib15","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1093\/rheumatology\/kes142","article-title":"Sensitivity and discriminatory ability of the ankylosing spondylitis disease activity score in patients treated with etanercept or sulphasalazine in the ASCEND trial","volume":"51","author":"van der Heijde","year":"2012","journal-title":"Rheumatology"},{"key":"10.1136\/annrheumdis-2022-222747_bib16","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1016\/S0140-6736(18)31946-9","volume":"392","author":"van der Heijde","year":"2018","journal-title":"Lancet"},{"key":"10.1136\/annrheumdis-2022-222747_bib17","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1016\/S0140-6736(19)32534-6","article-title":"Efficacy and safety of upadacitinib in patients with active ankylosing spondylitis (SELECT-AXIS 1): a multicentre, randomised, double-blind, placebo-controlled, phase 2\/3 trial","volume":"394","author":"van der Heijde","year":"2019","journal-title":"Lancet"},{"key":"10.1136\/annrheumdis-2022-222747_bib18","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1136\/annrheumdis-2012-201766","article-title":"Efficacy and safety of adalimumab in patients with non-radiographic axial spondyloarthritis: results of a randomised placebo-controlled trial (ABILITY-1)","volume":"72","author":"Sieper","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2022-222747_bib19","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0140-6736(19)32971-X","article-title":"Ixekizumab for patients with non-radiographic axial spondyloarthritis (COAST-X): a randomised, placebo-controlled trial","volume":"395","author":"Deodhar","year":"2020","journal-title":"Lancet"},{"key":"10.1136\/annrheumdis-2022-222747_bib20","first-page":"817","article-title":"Active inflammatory lesions detected by magnetic resonance imaging in the spine of patients with spondyloarthritis \u2013 definitions, assessment system, and reference image set","author":"Lambert","year":"2009","journal-title":"The Journal of Rheumatology"},{"key":"10.1136\/annrheumdis-2022-222747_bib21","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1002\/art.10883","article-title":"Magnetic resonance imaging examinations of the spine in patients with ankylosing spondylitis, before and after successful therapy with infliximab: evaluation of a new scoring system","volume":"48","author":"Braun","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2022-222747_bib22","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/1477-7525-1-79","article-title":"The functional assessment of chronic illness therapy (FACIT) measurement system: properties, applications, and interpretation","volume":"1","author":"Webster","year":"2003","journal-title":"Health Qual Life Outcomes"},{"key":"10.1136\/annrheumdis-2022-222747_bib23","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1136\/ard.2008.094870","article-title":"Development of an ASAS-endorsed disease activity score (ASDAS) in patients with ankylosing spondylitis","volume":"68","author":"Lukas","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2022-222747_bib24","first-page":"2286","article-title":"A new approach to defining disease status in ankylosing spondylitis: the Bath ankylosing spondylitis disease activity index","volume":"21","author":"Garrett","year":"1994","journal-title":"J Rheumatol"},{"key":"10.1136\/annrheumdis-2022-222747_bib25","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1002\/art.21445","article-title":"Spondyloarthritis research Consortium of Canada magnetic resonance imaging index for assessment of sacroiliac joint inflammation in ankylosing spondylitis","volume":"53","author":"Maksymowych","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2022-222747_bib26","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1002\/art.21337","article-title":"Spondyloarthritis research Consortium of Canada magnetic resonance imaging index for assessment of spinal inflammation in ankylosing spondylitis","volume":"53","author":"Maksymowych","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2022-222747_bib27","first-page":"2050","article-title":"Scoring sacroiliac joints by magnetic resonance imaging. A multiple-reader reliability experiment","volume":"32","author":"Landew\u00e9","year":"2005","journal-title":"J Rheumatol"},{"key":"10.1136\/annrheumdis-2022-222747_bib28","first-page":"862","article-title":"Scoring inflammatory activity of the spine by magnetic resonance imaging in ankylosing spondylitis: a multireader experiment","volume":"34","author":"Lukas","year":"2007","journal-title":"J Rheumatol"},{"issue":"Suppl 2","key":"10.1136\/annrheumdis-2022-222747_bib29","doi-asserted-by":"crossref","first-page":"ii1","DOI":"10.1136\/ard.2008.104018","article-title":"The assessment of spondyloarthritis International Society (ASAS) Handbook: a guide to assess spondyloarthritis","volume":"68","author":"Sieper","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2022-222747_bib30","first-page":"2281","article-title":"A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath ankylosing spondylitis functional index","volume":"21","author":"Calin","year":"1994","journal-title":"J Rheumatol"},{"key":"10.1136\/annrheumdis-2022-222747_bib31","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1136\/annrheumdis-2017-212076","article-title":"Measurement properties of the ASAS health index: results of a global study in patients with axial and peripheral spondyloarthritis","volume":"77","author":"Kiltz","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2022-222747_bib32","first-page":"As264","article-title":"Comparison of methods for the scoring and statistical analysis of SF-36 health profile and summary measures: summary of results from the medical outcomes study","volume":"33","author":"Ware","year":"1995","journal-title":"Med Care"},{"key":"10.1136\/annrheumdis-2022-222747_bib33","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1136\/annrheumdis-2011-201038","article-title":"ASAS recommendations for variables to be collected in clinical trials\/epidemiological studies of spondyloarthritis","volume":"71","author":"Dougados","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2022-222747_bib34","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1136\/ard.62.2.127","article-title":"Assessment of enthesitis in ankylosing spondylitis","volume":"62","author":"Heuft-Dorenbosch","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2022-222747_bib35","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1136\/ard.2007.084244","article-title":"Development and validation of the spondyloarthritis research Consortium of Canada (SPARCC) Enthesitis index","volume":"68","author":"Maksymowych","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2022-222747_bib36","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1136\/ard.2004.020503","article-title":"Assessment of outcome in ankylosing spondylitis: an extended radiographic scoring system","volume":"64","author":"Creemers","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2022-222747_bib37","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/art.1780270401","article-title":"Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the new York criteria","volume":"27","author":"van der Linden","year":"1984","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2022-222747_bib38","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3899\/jrheum.140519","article-title":"Development and preliminary validation of the spondyloarthritis research Consortium of Canada magnetic resonance imaging sacroiliac joint structural score","volume":"42","author":"Maksymowych","year":"2015","journal-title":"J Rheumatol"},{"key":"10.1136\/annrheumdis-2022-222747_bib39","first-page":"S441","article-title":"Can a historical cohort of patients with ankylosing spiondylitis containing data of 2-year radiographic progression serve as a control group to assess inhibition of structural damage by TNF-blockers?","volume":"48","author":"Van der Heijde","year":"2003","journal-title":"Arthritis and Rheumatism"},{"key":"10.1136\/annrheumdis-2022-222747_bib40","doi-asserted-by":"crossref","first-page":"e001654","DOI":"10.1136\/rmdopen-2021-001654","article-title":"Biological DMARDs and disease modification in axial spondyloarthritis: a review through the lens of causal inference","volume":"7","author":"Sepriano","year":"2021","journal-title":"RMD Open"},{"key":"10.1136\/annrheumdis-2022-222747_bib41","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1016\/j.semarthrit.2021.08.011","article-title":"The evolution of instrument selection for inclusion in core outcome sets at OMERACT: filter 2.2","volume":"51","author":"Maxwell","year":"2021","journal-title":"Semin Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2022-222747_bib42","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1186\/s13075-020-02262-4","article-title":"Assessing the effect of interventions for axial spondyloarthritis according to the endorsed ASAS\/OMERACT core outcome set: a meta-research study of trials included in Cochrane reviews","volume":"22","author":"Andreasen","year":"2020","journal-title":"Arthritis Res Ther"},{"key":"10.1136\/annrheumdis-2022-222747_bib43","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1007\/s00296-013-2789-x","article-title":"Performance of response scales of activity and functional measures of ankylosing spondylitis: numerical rating scale versus visual analog scale","volume":"33","author":"Akad","year":"2013","journal-title":"Rheumatol Int"},{"key":"10.1136\/annrheumdis-2022-222747_bib44","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/art.10397","article-title":"Use of a numerical rating scale as an answer modality in ankylosing spondylitis-specific questionnaires","volume":"47","author":"Van Tubergen","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2022-222747_bib45","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1136\/annrheumdis-2019-216256","article-title":"Use of composite outcomes facilitate core outcome set uptake in rheumatoid arthritis trials","volume":"79","author":"Kirkham","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2022-222747_bib46","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1136\/annrheumdis-2020-216999","article-title":"Use of multidimensional composite scores in rheumatology: parsimony versus subtlety","volume":"80","author":"Landew\u00e9","year":"2021","journal-title":"Ann Rheum Dis"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724083894?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724083894?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/annrheumdis-2022-222747","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,18]],"date-time":"2025-01-18T23:27:30Z","timestamp":1737242850000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724083894"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":46,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["S0003496724083894"],"URL":"https:\/\/doi.org\/10.1136\/annrheumdis-2022-222747","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Instrument selection for the ASAS core outcome set for axial spondyloarthritis","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/annrheumdis-2022-222747","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2023 \u00a9 Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by Elsevier Inc. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}